British Journal of Cancer - Table of Contents alert Volume 107 Issue 1

TABLE OF CONTENTS Volume 107, Issue 1 (1-220) Published online 26 June 2012 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letters to the Editor Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement British Journal of Cancer publishes high quality original papers and reviews that make a significant contribution to increasing understanding of the causes of cancer and to improving the treatment and survival of patients. Visit the journal online at www.bjcancer.com to view the latest research and access selected articles FREE of charge.   Clinical Studies Top A systemic review of Toxic Death in clinical oncology trials: an Achilles’ heel in safety reporting revisited B Penninckx, W M Van de Voorde, A Casado, N Reed, C Moulin and M Karrasch Br J Cancer 2012 107: 1-6; advance online publication, June 7, 2012; 10.1038/bjc.2012.252 Abstract | Full Text Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer R L Aft, M Naughton, K Trinkaus and K Weilbaecher Br J Cancer 2012 107: 7-11; advance online publication, May 22, 2012; 10.1038/bjc.2012.210 Abstract | Full Text Small but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in the Netherlands M J Aarts, V C Hamelinck, E Bastiaannet, J W W Coebergh, G J Liefers, A C Voogd, M van der Sangen and W J Louwman Br J Cancer 2012 107: 12-17; advance online publication, May 17, 2012; 10.1038/bjc.2012.205 Abstract | Full Text Mammographic density and molecular subtypes of breast cancer L Eriksson, P Hall, K Czene, I dos Santos Silva, V McCormack, J Bergh, J Bjohle and A Ploner Br J Cancer 2012 107: 18-23; advance online publication, May 29, 2012; 10.1038/bjc.2012.234 Abstract | Full Text Long-term results of screening with magnetic resonance imaging in women with BRCA mutations K Passaperuma, E Warner, P A Causer, K A Hill, S Messner, J W Wong, R A Jong, F C Wright, M J Yaffe, E A Ramsay, S Balasingham, L Verity, A Eisen, B Curpen, R Shumak, D B Plewes and S A Narod Br J Cancer 2012 107: 24-30; advance online publication, May 15, 2012; 10.1038/bjc.2012.204 Abstract | Full Text Translational Therapeutics Top Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer E Mochiki, K Ogata, T Ohno, Y Toyomasu, N Haga, Y Fukai, R Aihara, H Ando, N Uchida, T Asao and H Kuwano North Kanto Gastric Cancer Study Group Br J Cancer 2012 107: 31-36; advance online publication, May 22, 2012; 10.1038/bjc.2012.222 Abstract | Full Text Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients D Lorusso, G Scambia, G Amadio, A di Legge, A Pietragalla, R De Vincenzo, V Masciullo, M Di Stefano, G Mangili, G Citterio, M Mantori, A Lambiase and C Bordignon Br J Cancer 2012 107: 37-42; advance online publication, May 29, 2012; 10.1038/bjc.2012.233 Abstract | Full Text CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling A Dubrovska, A Hartung, L C Bouchez, J R Walker, V A Reddy, C Y Cho and P G Schultz Br J Cancer 2012 107: 43-52; advance online publication, May 29, 2012; 10.1038/bjc.2012.105 Abstract | Full Text A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice M Wehenkel, J-O Ban, Y-K Ho, K C Carmony, J T Hong and K B Kim Br J Cancer 2012 107: 53-62; advance online publication, June 7, 2012; 10.1038/bjc.2012.243 Abstract | Full Text Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo B Gibert, B Eckel, V Gonin, D Goldschneider, J Fombonne, B Deux, P Mehlen, A-P Arrigo, P Clézardin and C Diaz-Latoud Br J Cancer 2012 107: 63-70; advance online publication, May 24, 2012; 10.1038/bjc.2012.188 Abstract | Full Text Molecular Diagnostics Top Chromosome instability and benefit from adjuvant anthracyclines in breast cancer A F Munro, C Twelves, J S Thomas, D A Cameron and J MS Bartlett Br J Cancer 2012 107: 71-74; advance online publication, May 29, 2012; 10.1038/bjc.2012.232 Abstract | Full Text NT5E CpG island methylation is a favourable breast cancer biomarker C Lo Nigro, M Monteverde, S Lee, L Lattanzio, D Vivenza, A Comino, N Syed, A McHugh, H Wang, C Proby, O Garrone, M Merlano, E Hatzimichael, E Briasoulis, O Gojis, C Palmieri, L Jordan, P Quinlan, A Thompson and T Crook Br J Cancer 2012 107: 75-83; advance online publication, May 31, 2012; 10.1038/bjc.2012.212 Abstract | Full Text pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant A Brunner, P Riss, G Heinze and H Brustmann Br J Cancer 2012 107: 84-90; advance online publication, May 29, 2012; 10.1038/bjc.2012.198 Abstract | Full Text Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival C H Choi, J-J Choi, Y-A Park, Y-Y Lee, S Y Song, C O Sung, T Song, M-K Kim, T-J Kim, J-W Lee, H-J Kim, D-S Bae and B-G Kim Br J Cancer 2012 107: 91-99; advance online publication, May 29, 2012; 10.1038/bjc.2012.217 Abstract | Full Text Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence M Truong, B Yang, J Wagner, Y Kobayashi, V Rajamanickam, J Brooks and D F Jarrard Br J Cancer 2012 107: 100-107; advance online publication, May 17, 2012; 10.1038/bjc.2012.216 Abstract | Full Text High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia J H Song, S H Kweon, H-J Kim, T-H Lee, W-S Min, H-J Kim, Y-K Kim, S Y Hwang and T S Kim Br J Cancer 2012 107: 108-115; advance online publication, May 24, 2012; 10.1038/bjc.2012.206 Abstract | Full Text Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma L Dyrskjøt, K Zieger, T Kissow Lildal, T Reinert, O Gruselle, T Coche, M Borre and T F Ørntoft Br J Cancer 2012 107: 116-122; advance online publication, May 17, 2012; 10.1038/bjc.2012.215 Abstract | Full Text An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer S Miah, E Dudziec, R M Drayton, A R Zlotta, S L Morgan, D J Rosario, F C Hamdy and J W F Catto Br J Cancer 2012 107: 123-128; advance online publication, May 29, 2012; 10.1038/bjc.2012.221 Abstract | Full Text Inhibition of transforming growth factor-β-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasis D M Ray, P H Myers, J T Painter, M J Hoenerhoff, K Olden and J D Roberts Br J Cancer 2012 107: 129-136; advance online publication, May 29, 2012; 10.1038/bjc.2012.214 Abstract | Full Text Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer T Einama, S Homma, H Kamachi, F Kawamata, K Takahashi, N Takahashi, M Taniguchi, T Kamiyama, H Furukawa, Y Matsuno, S Tanaka, H Nishihara, A Taketomi and S Todo Br J Cancer 2012 107: 137-142; advance online publication, May 29, 2012; 10.1038/bjc.2012.235 Abstract | Full Text mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma J P Baren, G D Stewart, A Stokes, K Gray, C J Pennington, R O'Neill, D A C Deans, S Paterson-Brown, A C P Riddick, D R Edwards, K C H Fearon, J A Ross and R J E Skipworth Br J Cancer 2012 107: 143-149; advance online publication, June 7, 2012; 10.1038/bjc.2012.239 Abstract | Full Text Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer L Ohlsson, G Lindmark, A Israelsson, R Palmqvist, Å Öberg, M-L Hammarström and S Hammarström Br J Cancer 2012 107: 150-157; advance online publication, June 14, 2012; 10.1038/bjc.2012.220 Abstract | Full Text Epidemiology Top The relationship between vitamin D and chemotherapy-induced toxicity – a pilot study D Kitchen, B Hughes, I Gill, M O'Brien, S Rumbles, P Ellis, P Harper, J Stebbing and N Rohatgi Br J Cancer 2012 107: 158-160; advance online publication, May 15, 2012; 10.1038/bjc.2012.194 Abstract | Full Text Prognosis and prognostic factors of patients with mesothelioma: a population-based study S van der Bij, H Koffijberg, J A Burgers, P Baas, M J van de Vijver, B A J M de Mol and K G M Moons Br J Cancer 2012 107: 161-164; advance online publication, May 29, 2012; 10.1038/bjc.2012.245 Abstract | Full Text Leg length, sitting height and postmenopausal breast cancer risk L Mellemkjær, J Christensen, K Frederiksen, J L Baker, A Olsen, T I A Sørensen and A Tjønneland Br J Cancer 2012 107: 165-168; advance online publication, June 7, 2012; 10.1038/bjc.2012.244 Abstract | Full Text Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study T Y O Yang, B J Cairns, N Allen, S Sweetland, G K Reeves and V Beral on behalf of the Million Women Study Br J Cancer 2012 107: 169-175; advance online publication, May 29, 2012; 10.1038/bjc.2012.229 Abstract | Full Text Hypertensive diseases in pregnancy and breast cancer risk S Opdahl, P R Romundstad, M D K Alsaker and L J Vatten Br J Cancer 2012 107: 176-182; advance online publication, May 10, 2012; 10.1038/bjc.2012.195 Abstract | Full Text Registration of cancer in girls remains lower than expected in countries with low/middle incomes and low female education rates S S Bhopal, K D Mann and M S Pearce Br J Cancer 2012 107: 183-188; advance online publication, May 10, 2012; 10.1038/bjc.2012.191 Abstract | Full Text Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone N Cavalli-Björkman, C Qvortrup, S Sebjørnsen, P Pfeiffer, T Wentzel-Larsen, B Glimelius and H Sorbye Br J Cancer 2012 107: 189-194; advance online publication, May 10, 2012; 10.1038/bjc.2012.186 Abstract | Full Text Risk of liver cancer among US male veterans with cirrhosis, 1969–1996 E C Persson, S M Quraishi, T M Welzel, J D Carreon, G Gridley, B I Graubard and K A McGlynn Br J Cancer 2012 107: 195-200; advance online publication, May 15, 2012; 10.1038/bjc.2012.193 Abstract | Full Text Men with cancer change their health behaviour: a prospective study from the Danish Diet, Cancer and Health Study R V Karlsen, P E Bidstrup, J Christensen, S B Larsen, A Tjønneland, S O Dalton and C Johansen Br J Cancer 2012 107: 201-206; advance online publication, May 29, 2012; 10.1038/bjc.2012.238 Abstract | Full Text Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study F M Shebl, L C Sakoda, A Black, J Koshiol, G L Andriole, R Grubb, T R Church, D Chia, C Zhou, L W Chu, W-Y Huang, U Peters, V A Kirsh, N Chatterjee, M F Leitzmann, R B Hayes and A W Hsing Br J Cancer 2012 107: 207-214; advance online publication, June 21, 2012; 10.1038/bjc.2012.227 Abstract | Full Text Letters to the Editor Top Childhood leukaemia and socioeconomic status S Franceschi Br J Cancer 2012 107: 215; advance online publication, June 12, 2012; 10.1038/bjc.2012.170 Full Text Reply: ‘Childhood leukaemia and socioeconomic status’ M E Kroll, C A Stiller and M F G Murphy Br J Cancer 2012 107: 216; advance online publication, June 12, 2012; 10.1038/bjc.2012.171 Full Text Comment on ‘Childhood leukaemia and socioeconomic status in England and Wales 1976–2005: evidence of higher incidence in relatively affluent communities persists over time’ A Smith, T Lightfoot and E Roman Br J Cancer 2012 107: 217-218; advance online publication, June 12, 2012; 10.1038/bjc.2012.179 Full Text Reply to: ‘Childhood leukaemia and socioeconomic status in England and Wales 1976–2005: evidence of higher incidence in relatively affluent communities persists over time’ M E Kroll, C A Stiller and M F G Murphy Br J Cancer 2012 107: 219-220; advance online publication, June 12, 2012; 10.1038/bjc.2012.180 Full Text Advertisement Ensure your access to British Journal of Cancer If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeCommRequest?id=2.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.